Description

Book Synopsis
The book "Drug Selectivity - An Evolving Concept in Medicinal Chemistry" provides a current overview and comprehensive compilation for medicinal chemists that discusses the effects of aiming for multiple targets on the entire drug development process.
The result is a broad survey of current and future strategies for drug selectivity in medicinal chemistry with theoretical but also practical aspects. Different strategies are presented and evaluated, such as various design approaches, merged multiple ligands, discovery technologies and a broad range of successful examples of unselective drugs taken from all major disease areas. With its wide-ranging view of an emerging new paradigm in drug development, this handbook is of prime importance for every medicinal and pharmaceutical chemist.


Trade Review
In summary, this is a very good and valuable book for graduate students as well as medicinal chemists in academia and pharmaceutical companies. Readers will find many interesting chapters, some of which are more oriented to experts, while others are well suited for beginners. I recommend this book to those working in the field of medicinal chemistry, or even pharmacology, who have a particular interest in selective and selectively nonselective drugs. (Prof. Antonio Macchiarulo, ChemMedChem 19/2018)

Table of Contents
PART I. INTRODUCTION
Polypharmacology in Drug Discovery

PART II. SELECTIVITY OF MARKTETED DRUGS
Kinase Inhibitors
New Indications for Marketed Drugs
Discovery Technologies of New Indications

PART III. FIXED-DOSE COMBINATIONS
The Growing Market of Fixed-Dose Combinations

PART IV. UNSELECTIVE DRUGS IN DRUG DISCOVERY
The Growing Importance of Individualising Drugs
Drug Discovery Strategies for the Generation of Multi-Target Ligands against Neglected Tropical Diseases
Designing-In Approach
The Linker Approach (Drug-Conjugates)
Merged Multiple Ligands
Pharmacophore Generation of Multiple Ligands
Cellular Assays

PART V. THERAPEUTIC AREAS FOR DESIGNED MULTIPLE LIGANDS
5HT Transporter-Based Multiple Ligands for Depression
Multiple Ligands Targeting the Angiotensin System for Hypertension
PPAR-Based Multiple Ligands for Metabolic Disease
Antibiotics
Multiple Ligands in Cancer Therapy
Multiple Ligands in Neurodegenerative Diseases

Drug Selectivity: An Evolving Concept in

    Product form

    £999.99

    Includes FREE delivery

    A Hardback by Norbert Handler, Helmut Buschmann, Raimund Mannhold

    Out of stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Drug Selectivity: An Evolving Concept in by Norbert Handler

      Publisher: Wiley-VCH Verlag GmbH
      Publication Date: 10/01/2018
      ISBN13: 9783527335381, 978-3527335381
      ISBN10: 3527335382

      Description

      Book Synopsis
      The book "Drug Selectivity - An Evolving Concept in Medicinal Chemistry" provides a current overview and comprehensive compilation for medicinal chemists that discusses the effects of aiming for multiple targets on the entire drug development process.
      The result is a broad survey of current and future strategies for drug selectivity in medicinal chemistry with theoretical but also practical aspects. Different strategies are presented and evaluated, such as various design approaches, merged multiple ligands, discovery technologies and a broad range of successful examples of unselective drugs taken from all major disease areas. With its wide-ranging view of an emerging new paradigm in drug development, this handbook is of prime importance for every medicinal and pharmaceutical chemist.


      Trade Review
      In summary, this is a very good and valuable book for graduate students as well as medicinal chemists in academia and pharmaceutical companies. Readers will find many interesting chapters, some of which are more oriented to experts, while others are well suited for beginners. I recommend this book to those working in the field of medicinal chemistry, or even pharmacology, who have a particular interest in selective and selectively nonselective drugs. (Prof. Antonio Macchiarulo, ChemMedChem 19/2018)

      Table of Contents
      PART I. INTRODUCTION
      Polypharmacology in Drug Discovery

      PART II. SELECTIVITY OF MARKTETED DRUGS
      Kinase Inhibitors
      New Indications for Marketed Drugs
      Discovery Technologies of New Indications

      PART III. FIXED-DOSE COMBINATIONS
      The Growing Market of Fixed-Dose Combinations

      PART IV. UNSELECTIVE DRUGS IN DRUG DISCOVERY
      The Growing Importance of Individualising Drugs
      Drug Discovery Strategies for the Generation of Multi-Target Ligands against Neglected Tropical Diseases
      Designing-In Approach
      The Linker Approach (Drug-Conjugates)
      Merged Multiple Ligands
      Pharmacophore Generation of Multiple Ligands
      Cellular Assays

      PART V. THERAPEUTIC AREAS FOR DESIGNED MULTIPLE LIGANDS
      5HT Transporter-Based Multiple Ligands for Depression
      Multiple Ligands Targeting the Angiotensin System for Hypertension
      PPAR-Based Multiple Ligands for Metabolic Disease
      Antibiotics
      Multiple Ligands in Cancer Therapy
      Multiple Ligands in Neurodegenerative Diseases

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account